Digital health Company Methinks has received a CE mark for its medical imaging software, Methinks Stroke Suite, designed to help in emergency settings for the benefit of acute stroke (AS) patients.

Methinks Stroke Suite is said to be the first CE-marked medical device that is capable of finding large vessel occlusions (LVO), both hyperdense and not, from non-contrast computed tomographies (NCCT) images.

Methinks, which is based in Barcelona, Spain, has designed the radiological computer-aided triage and notification system to detect suspected LVO on NCCT images as well as on computed tomography angiography (CTA).

The software, which uses artificial intelligence (AI) algorithms, can also detect intracerebral haemorrhages (ICH) on NCCT images.

According to the digital health company, the programme triages AS patients early, quickly, and precisely by operating in parallel with the clinical workflows. It uses CT scans that are available in all hospitals for AS.

Methinks CEO Pau Rodriguez said: “We are delighted with the CE mark approval for our medical imaging software, Methinks Stroke Suite, which paves the way to enhance stroke patient outcomes by decreasing detection time and reducing disabilities.

“Our software has the potential to be used in every hospital globally to improve the standard of care of patients.

“The approval comes at a pivotal time ahead of US FDA submission and launching a series A financing to accelerate our growth plans by leveraging and personalising imaging software.”

Additionally, Methinks Stroke Suite can help qualified doctors support critical care and triage in emergency cases by informing them of suspected ICH and LVO cases. Its ability has been validated in 3,800 cases from three separate stroke reference hospitals.

Methinks said that the CE-mark certification will enable the commercialisation of the stroke triage software in Europe.

The Spanish digital health company is involved in the development of AI-based medical imaging software to identify cerebral artery occlusions and haemorrhages.